newsfilter
← Latest News
GlobeNewswire·

I-Mab Regains Compliance with Nasdaq Minimum Bid Price Requirement

ROCKVILLE, Md., June 12, 2025 (GLOBE NEWSWIRE) -- I-Mab (NASDAQ:IMAB) ("I-Mab" or the "Company"), a U.S.-based, global biotech company, focused on the development of precision immuno-oncology agents for the treatment